BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loirat C, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura in children. Curr Opin Pediatr 2013;25:216-24. [PMID: 23422353 DOI: 10.1097/MOP.0b013e32835e7888] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Shi HP, Wang ZY. [New progress in clinical significance of ADAMTS13]. Zhonghua Xue Ye Xue Za Zhi 2017;38:903-6. [PMID: 29166749 DOI: 10.3760/cma.j.issn.0253-2727.2017.10.018] [Reference Citation Analysis]
2 Alias H, Yong WL, Muttlib FAA, Koo HW, Loh CK, Lau SCD, Alauddin H, Azma RZ. Acquired thrombotic thrombocytopenia purpura associated with severe ADAMTS13 deficiency in a 3-year-old boy: a case report and review of the literature. J Med Case Rep 2018;12:276. [PMID: 30223886 DOI: 10.1186/s13256-018-1806-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Sadler JE. What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2015;2015:631-6. [PMID: 26637781 DOI: 10.1182/asheducation-2015.1.631] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
4 Li P, Jiang J, Xi Q, Yang Z. An ADAMTS13 mutation that causes hereditary thrombotic thrombocytopenic purpura: a case report and literature review. BMC Med Genomics 2021;14:252. [PMID: 34702267 DOI: 10.1186/s12920-021-01099-3] [Reference Citation Analysis]
5 Sarig G. ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies. Rambam Maimonides Med J 2014;5:e0026. [PMID: 25386342 DOI: 10.5041/RMMJ.10160] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bacchetta J, Cochat P. Primary disease recurrence—effects on paediatric renal transplantation outcomes. Nat Rev Nephrol 2015;11:371-84. [PMID: 25917555 DOI: 10.1038/nrneph.2015.54] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
7 Rurali E, Banterla F, Donadelli R, Bresin E, Galbusera M, Gastoldi S, Peyvandi F, Underwood M, Remuzzi G, Noris M. ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment. Clin J Am Soc Nephrol 2015;10:2002-12. [PMID: 26342041 DOI: 10.2215/CJN.01700215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
8 Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016;31:15-39. [PMID: 25859752 DOI: 10.1007/s00467-015-3076-8] [Cited by in Crossref: 272] [Cited by in F6Publishing: 210] [Article Influence: 38.9] [Reference Citation Analysis]
9 Günay N, Pınarbaşı AS, Dursun İ, Yel S, Poyrazoğlu MH, Düşünsel R. A child with anemia, thrombocytopenia, renal failure and elevated amylase, and lipase enzymes: Answers. Pediatr Nephrol 2019;34:1219-21. [PMID: 30569311 DOI: 10.1007/s00467-018-4169-y] [Reference Citation Analysis]